Rapid Fire Session 1: Transplant and VADS
Moderator:
Mazen Hanna, MD
Presentations:
Phase 1 Study of Daratumumab-Hyaluronidase for Reduction of Circulating Antibodies in Patients with High Allosensitization Awaiting Heart Transplantation
Ronald Witteles, MD, FHFSA
Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Post-Heart Transplant Patients: A Multi-Center Retrospective Cohort Study
Priya Umapathi, MD
Long Term Outcomes after LVAD Weaning for Myocardial Recovery: Results from the VAD Wean Recovery Network
Stavros Drakos, MD
First-In-Human Implantation of a Next-Generation Membrane-Based LVAD
Chris Hayward
Long Term Trajectory of Glomerular Filtration Rate Post-LAVD and the Impact on Clinical Outcomes: An analysis of the MOMEMTUM 3 Study
Nir Uriel, MD
Increased LVEF at Six Months Following LVAD Implant is Associated with Improved Long-Term Outcomes - A MOMENTUM-3 Analysis
Eduardo Rame, MD
Screening for advanced heart failure in stable outpatients (The SAINTS study)
Benjamin Hansen